Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement.
Saved in:
| Title: | Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement. |
|---|---|
| Authors: | Peluso MJ; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA., Kelly JD; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.; Institute of Global Health Sciences, University of California, San Francisco, San Francisco, California, USA.; F.I. Proctor Foundation, University of California, San Francisco, San Francisco, California, USA., Lu S; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Goldberg SA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Davidson MC; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Mathur S; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Durstenfeld MS; Division of Cardiology, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA., Spinelli MA; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA., Hoh R; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA., Tai V; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA., Fehrman EA; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA., Torres L; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA.; Division of Experimental Medicine, University of California, San Francisco, San Francisco, California, USA., Hernandez Y; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA., Williams MC; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA., Arreguin MI; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA., Ngo LH; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA., Deswal M; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA., Munter SE; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA.; Division of Experimental Medicine, University of California, San Francisco, San Francisco, California, USA., Martinez EO; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Anglin KA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Romero MD; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Tavs J; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Rugart PR; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Chen JY; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.; Division of Experimental Medicine, University of California, San Francisco, San Francisco, California, USA., Sans HM; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Murray VW; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA., Ellis PK; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Donohue KC; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Massachi JA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Weiss JO; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Mehdi I; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Pineda-Ramirez J; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Tang AF; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Wenger MA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Assenzio MT; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Yuan Y; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Krone MR; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Rutishauser RL; Division of Experimental Medicine, University of California, San Francisco, San Francisco, California, USA., Rodriguez-Barraquer I; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA., Greenhouse B; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA., Sauceda JA; Center for AIDS Prevention Studies, University of California, San Francisco, San Francisco, California, USA., Gandhi M; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA., Scheffler AW; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Hsue PY; Division of Cardiology, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA., Henrich TJ; Division of Experimental Medicine, University of California, San Francisco, San Francisco, California, USA., Deeks SG; Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA., Martin JN; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA. |
| Source: | Open forum infectious diseases [Open Forum Infect Dis] 2021 Dec 21; Vol. 9 (2), pp. ofab640. Date of Electronic Publication: 2021 Dec 21 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2328-8957 |
|---|---|
| DOI: | 10.1093/ofid/ofab640 |
